Comparison 39. Oral misoprostol versus delayed vaginal postaglandins (12): all women.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Vaginal delivery not achieved in 24 hours	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.52 [0.32, 0.83]
1.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.52 [0.32, 0.83]
2 Uterine hyperstimulation with FHR changes	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Caesarean section	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.33, 3.21]
3.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.33, 3.21]
4 Oxytocin augmentation	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.81 [0.44, 1.49]
4.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.81 [0.44, 1.49]
5 Uterine hyperstimulation without FHR changes	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.16, 6.87]
5.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.16, 6.87]
6 Instrumental vaginal delivery	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	1.26 [0.61, 2.60]
6.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	1.26 [0.61, 2.60]
7 Apgar score < 7 at 5 minutes	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
8 Neonatal intensive care unit admission	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	3.10 [0.13, 73.16]
8.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	3.10 [0.13, 73.16]
9 Nausea	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.69 [0.22, 2.20]
9.1 50 mcg	1	61	Risk Ratio (M‐H, Fixed, 95% CI)	0.69 [0.22, 2.20]
10 Oxytocin augmentation	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]